Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

CA209370: A Master Protocol of Phase 1/2 Studies of Nivolumab in Advanced NSCLC Using Nivolumab as Maintenance after Induction Chemotherapy or as First-line Treatment Alone or in Combination with Standard of Care Therapies

  • Details

ClinicalTrials.gov ID: NCT02574078
Diagnosis Type: NSCLC
USOR Number: 14158

  • Practice Details

520 Country Club Rd
Eugene, Oregon 97401
P: (888) 384-9822

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Springfield

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

3377 Riverbend Drive, Suite 500
Springfield, Oregon 97477
P: (888) 384-9822

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

520 Country Club Rd
Eugene, Oregon 97401
P: (888) 384-9822

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

520 Country Club Rd
Eugene, Oregon 97401
P: (888) 384-9822

More Details View Practice Page

GI Stromal Tumor (GIST)

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Springfield

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

3377 Riverbend Drive, Suite 500
Springfield, Oregon 97477
P: (888) 384-9822

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Springfield

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

3377 Riverbend Drive, Suite 500
Springfield, Oregon 97477
P: (888) 384-9822

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

520 Country Club Rd
Eugene, Oregon 97401
P: (888) 384-9822

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Springfield

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

3377 Riverbend Drive, Suite 500
Springfield, Oregon 97477
P: (888) 384-9822

More Details View Practice Page

Leukemia

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

informCLL™: A Disease Registry for Patients with Chronic Lymphocytic Leukemia (PCYC-1134M-CA)

  • Details

ClinicalTrials.gov ID: NCT02582879
Diagnosis Type: CLL
USOR Number: 15005

  • Practice Details

520 Country Club Rd
Eugene, Oregon 97401
P: (888) 384-9822

More Details View Practice Page

Pages